DENTSPLY SIRONA Inc. (XRAY) Given Average Recommendation of “Buy” by Brokerages

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have been given an average recommendation of “Buy” by the eleven brokerages that are presently covering the firm. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $65.57.

XRAY has been the subject of a number of analyst reports. Zacks Investment Research cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, January 9th. Barrington Research raised DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $63.00 price objective for the company in a report on Monday, December 5th. Morgan Stanley raised DENTSPLY SIRONA from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $65.00 to $69.00 in a report on Tuesday, November 1st. They noted that the move was a valuation call. Finally, Jefferies Group LLC cut their price objective on DENTSPLY SIRONA from $70.00 to $68.00 and set a “buy” rating for the company in a report on Monday, January 23rd.

COPYRIGHT VIOLATION WARNING: “DENTSPLY SIRONA Inc. (XRAY) Given Average Recommendation of “Buy” by Brokerages” was originally published by sleekmoney and is the property of of sleekmoney. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright legislation. The correct version of this piece of content can be accessed at http://sleekmoney.com/dentsply-sirona-inc-xray-given-average-recommendation-of-buy-by-brokerages/1657652.html.

Shares of DENTSPLY SIRONA (NASDAQ:XRAY) opened at 58.39 on Wednesday. DENTSPLY SIRONA has a one year low of $54.05 and a one year high of $65.83. The firm has a 50-day moving average of $57.48 and a 200-day moving average of $59.37. The firm has a market capitalization of $13.48 billion, a P/E ratio of 30.51 and a beta of 1.21.

In related news, CEO James G. Mosch sold 30,400 shares of DENTSPLY SIRONA stock in a transaction dated Thursday, November 17th. The stock was sold at an average price of $60.93, for a total value of $1,852,272.00. Following the completion of the sale, the chief executive officer now directly owns 75,283 shares in the company, valued at $4,586,993.19. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 2.20% of the stock is owned by company insiders.

A number of hedge funds have recently made changes to their positions in XRAY. Telemus Capital LLC raised its stake in shares of DENTSPLY SIRONA by 0.4% in the third quarter. Telemus Capital LLC now owns 7,852 shares of the company’s stock worth $467,000 after buying an additional 35 shares during the last quarter. Security National Bank of SO Dak raised its stake in shares of DENTSPLY SIRONA by 0.4% in the second quarter. Security National Bank of SO Dak now owns 17,491 shares of the company’s stock worth $1,085,000 after buying an additional 75 shares during the last quarter. Municipal Employees Retirement System of Michigan raised its stake in shares of DENTSPLY SIRONA by 0.5% in the third quarter. Municipal Employees Retirement System of Michigan now owns 19,460 shares of the company’s stock worth $1,157,000 after buying an additional 90 shares during the last quarter. Bbva Compass Bancshares Inc. raised its stake in shares of DENTSPLY SIRONA by 0.4% in the third quarter. Bbva Compass Bancshares Inc. now owns 22,324 shares of the company’s stock worth $1,326,000 after buying an additional 91 shares during the last quarter. Finally, Baird Financial Group Inc. raised its stake in shares of DENTSPLY SIRONA by 0.6% in the fourth quarter. Baird Financial Group Inc. now owns 15,958 shares of the company’s stock worth $921,000 after buying an additional 101 shares during the last quarter. Hedge funds and other institutional investors own 94.36% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/dentsply-sirona-inc-xray-given-average-recommendation-of-buy-by-brokerages/1657652.html

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *